AmplyCell SA - Company Review
SummaryAmplyCell SA - Company Review
Summary
AmplyCell SA (AmplyCell) is a biotechnology company that offers cell productivity and stability solutions. AmplyCell enables its customers to produce more protein out of their own cell lines based on its BOOST technology; and helps optimize, stabilize and increase monoclonal antibody production. The application of its treatment also optimizes hybridoma productivity. It utilizes Cell Fitness Technologies, which have a four-stage process to optimize cell lines. It serves contract manufacturing organizations, diagnostic and pharmaceutical firms, and research centers. AmplyCell’s cell boosting technology finds application in biologics including antibodies, enzymes, cytokines, highly glycosylated proteins, fusion proteins, vaccines, peptides, conjugates and PEGylated proteins. The company is a spin-off of Haute Ecole. AmplyCell is headquartered in Liege, Belgium.
This comprehensive company report of AmplyCell SA provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.